ERS International Congress, Madrid, 2019: highlights from the Interstitial Lung Diseases Assembly.

Although the primary end-point was not met, as the change in alveolar–arterial oxygen tension difference ( P A–aO 2 ) did not reach statistical significance, GM-CSF therapy was shown to decrease ground-glass opacities, and improve serum biomarkers, quality of life and D LCO .

also in 111,027 other papers